Company Legal Name
Latest Valuation
Founded Year
Headquarter
Cambrian Biopharma Inc. develops innovative therapeutics targeting the biological mechanisms of aging and age-related diseases. Founded in 2019 and headquartered in New York, the biotechnology company focuses on addressing fundamental aging processes rather than individual age-related conditions. Cambrian's approach represents a paradigm shift in healthcare, moving beyond traditional disease treatment to target the underlying drivers of aging itself. The company operates in the emerging longevity biotechnology sector, which has gained significant investor and scientific interest as populations age globally. Cambrian continues advancing its pipeline of aging-targeted therapeutics through preclinical and clinical development programs.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy Cambrian BioPharma pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of Cambrian BioPharma ?
The latest valuation of Cambrian BioPharma is , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in Cambrian BioPharma ?
The minimum investment is $10, enabling fractionalized access to Cambrian BioPharma pre-IPO shares.
What fees will I pay when investing in Cambrian BioPharma pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in Cambrian BioPharma pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my Cambrian BioPharma pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.